Cardiologist, Brigham and Women's Hospital, Boston, MA 02115
Brigham and Women's Hospital
Auburndale , Massachusetts, United States
Dr. Muller is a research cardiologist at the Brigham and Women's Hospital and Harvard Medical School. He is also CEO of ECHAS, LLC, a company building an app to help patients know when to call 911 for a heart attack or stroke. In the 1980s studies of circadian variation and triggering led to the concept of vulnerable coronary plaque. In 1998 Dr. Muller founded Infraredx, Inc to create a NIRS-IVUS catheter. Dr. Ron Waksman led the study demonstrating that NIRS can identify vulnerable plaques. The PROSPECT 2 study results also demonstrated detection of vulnerable plaques as have 6 other studies. In 2016 he co-founded SpectraWAVE, Inc. which has created an OCT-NIRS coronary catheter now approved by the FDA for detection of high risk plaques. In 2023 he was named Scientist of the Year - Basic by the ACC. He was a cofounder of IPPNW that won the 1985 Nobel Peace Prize.
No relationships to disclose
A Novel Smartphone App to Help Patients Know When to Call 911 for STEMI: Symptomsactor XI
Saturday, March 9, 2024
3:41 PM – 3:49 PM ET
PREVENT Trial | Why PREVENT will meet the Endpoint
Sunday, March 10, 2024
7:05 AM – 7:10 AM ET
Sunday, March 10, 2024
7:15 AM – 7:19 AM ET
Vulnerable Plaques Can Be Detected: What Are the Implications for Research and Clinical Practice?
Sunday, March 10, 2024
5:56 PM – 6:04 PM ET